1 – 10 of 177
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Apolipoprotein E genotypes and longevity across dementia disorders
- Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation : A 22-year follow-up study
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression : A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
- 2017
- Levels of cerebrospinal fluid biomarkers total tau and phosphorylated tau do not predict survival time after diagnosis of Alzheimer’s disease – An 18-year follow-up.
- Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
- Concordance between different amyloid immunoassays and Visual amyloid positron emission tomographic assessment
- Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease
- Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders